| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 3.9e-05 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 1.2e-05 | 1 |